The Federal Circuit’s operations are impacted by the COVID-19 pandemic. Please visit our COVID-19 page for more information.

20-1673: MYLAN PHARMACEUTICALS INC. v. BIOGEN MA INC. [OPINION], Nonprecedential

OPINION Posted:

MYLAN PHARMACEUTICALS INC. v. BIOGEN MA INC. [OPINION](pdf)
Appeal Number: 20-1673
Origin: PTO
Nonprecedential

To see more opinions and orders, follow this link: Opinions and Orders.